Nerve conduction studies in adrenomyeloneuropathy

Journal of Neurology Neurosurgery and Psychiatry

Volumn 61, Issue 2, 1996, Pages 181-185

  Chaudhry, Vinay ^a   Moser, Hugo W ^b   Cornblath, David R ^a  

^a JOHNS HOPKINS HOSPITAL   (United States)

^b JOHNS HOPKINS CHILDREN S CENTER   (United States)

Author keywords

Adrenomyeloneuropathy; Nerve conduction studies; Peripheral neuropathy

Indexed keywords

VERY LONG CHAIN FATTY ACID;

ADDISON DISEASE; ADOLESCENT; ADRENAL FUNCTION; ADULT; AGED; ARM; ARTICLE; CORRELATION FUNCTION; DEMYELINATION; FATTY ACID BLOOD LEVEL; FEMALE; HOFFMANN REFLEX; HUMAN; LATENT PERIOD; LEG; MAJOR CLINICAL STUDY; MALE; MEDIAN NERVE; MOTOR NERVE CONDUCTION; NERVE CONDUCTION; NEUROPATHY; PERIPHERAL NEUROPATHY; PERONEUS NERVE; PRIORITY JOURNAL; SENSORY NERVE CONDUCTION; SPASTIC PARAPLEGIA; SURAL NERVE;

EID: 0029841138     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.61.2.181     Document Type: Article

References (28)

1. Griffin JW, Goren E, Schaumburg H, Engel WK, Loriaux L. Adrenomyeloneuropathy: a probable variant of adrenoleukodystrophy. I. Clinical and endocrinologic aspects. Neurology 1977;27:1107-13.
2. Moser HW, Bergin A, Cornblath DR. Peroxisomal disorders. Biochem Cell Biol 1991;69:463-74.
3. Moser HW, Moser AB. Adrenoleukodystrophy (X-linked). In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The metabolic basis of inherited diseases. Vol 2. New York: McGrawHill, 1989:1511-32.
4. Moser HW, Moser AB, Smith KD, et al. Adrenoleukodystrophy: phenotypic variability and implications for therapy. J Inherit Metab Dis 1992;15:645-64.
5. Moser HW, Naidu S, Kumar AJ, Rosenbaum AE. Adrenoleukodystrophy: toward a biochemical definition of a disease with varied presentations. CRC Crit Rev Neurobiol 1987;31:29.
6. Moser HW, Moser AB, Naidu S, Bergin A. Clinical aspects of adrenoleukodystrophy and adrenomyeloneuropathy. Dev Neurosci 1991;13:254-61.
7. Budka H, Sluga E, Heiss WD. Spastic paraplegia associated with Addison's disease: adult variant of adrenoleukodystrophy. J Neurol 1976;213:237-50.
8. Dooley JM, Wright BA. Adrenoleukodystrophy mimicking multiple sclerosis. Can J Neurol Sci 1985;12:73-4.
9. Askanas V, McLaughlin J, King A, Engel W, Adornato BT. Abnormalities in cultured muscle and peripheral nerve of a patient with adrenomyeloneuropathy. N Engl J Med 1979;301:588-90.
10. Aubourg P, Adamsbaum C, Lavallard-Rousseau MC, et al. A two-year trial of oleic and erucic acids ("Lorenzo's oil") as treatment for adrenomyeloneuropathy. N Engl J Med 1993;329:745-52.
11. Aubourg P, Adamsbaum C, Lavallard-Rousseau MC, et al. Brain MRI and electrophysiologic abnormalities in pre-clinical and clinical adrenomyeloneuropathy. Neurology 1992;42:85-91.
12. Davis LE, Snyder RD, Orth DN, Nicholson WE, Kornfeld M, Seelinger DF. Adrenoleukodystrophy associated with partial adrenal insufficiency in three generations of a kindred. Am J Med 1979;66:342-7.
13. Martin JJ, Lowenthal A, Ceuterick C, Gacoms H. Adrenomyeloneuropathy: a report of two families. J Neurol 1982;226:221-32.
14. Vercruyssen A, Martin JJ, Mercelis R. Neurophysiological studies in adrenomyeloneuropathy: a report on five cases. J Neurol Sci 1982;56:327-36.
15. Berkovic SF, Zajac JD, Warburton DJ, et al. Adrenomyeloneuropathy: clinical and biochemical diagnosis. Aust N Z J Med 1983;13:594-600.
16. Noetzel MJ, Landau WM, Moser HW. Adrenoleukodystrophy: carrier state presenting as chronic nonprogressive spinal cord disorder. Arch Neurol 1987;44:566-7.
17. Elrington GM, Bateman DE, Jeffrey MJ. Adrenoleukodystrophy: heterogeneity in two brothers. J Neurol Neurosurg Psychiatry 1989;52:310-3.
18. van Geel BM, Koelman JHTM, Barth PG, Ongerboer de Visser BW. Peripheral nerve abnormalities in adrenomyeloneuropathy: a clinical and electrodiagnostic study. Neurology 1996;46:112-8.
19. Kaplan PW, Tusa RJ, Shankroff J, Heller J, Moser HW. Visual evoked potentials in adrenoleudodystrophy: a trial of glycerol trioleate and Lorenzo oil. Ann Neurol 1991; 34:169-74.
20. Cornblath DR, Asbury AK, Albers JW, et al. Research criteria for diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP). Neurology 1991;41:617-8.
21. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983;33:1444-52.
22. Brown MJ, Asbury AK. Diabetic neuropathy. Ann Neurol 1984;15:2-12.
23. Tanaka K, Koyama A, Koike R, Ohno T, Atsumi T, Miyatake T. Adrenomyeloneuropathy: a report of a family and electron microscopic findings in peripheral nerve. J Neurol 1985;232:73-8.
24. Tobimatsu S, Fukui R, Kato M, Kobayashi T, Kuroiwa Y. Multimodality evoked potentials in patients and carriers with adrenoleukodystrophy and adrenomyeloneuropathy. Electroenceph Clin Neurophysiol 1985;62:18-24.
25. Knazek RA, Rizzo WB, Schulman JD, Dave JR. Membrane microviscosity is increased in the erythrocytes of patients with adrenoleukodystrophy and adrenomyeloneuropathy. J Clin Invest 1983;72:245-8.
26. Whitcomb RW, Linehan WM, Knazek RA. Effects of long-chain, saturated fatty acids on membrane microviscosity and adrenocorticotropin responsiveness of human adrenoconical cells in vitro. J Clin Invest 1988;81:185-8.
27. Ho JK, Moser H, Kishimoto Y, Hamilton JA. Interactions of a very long chain fatty acid with model membranes and serum albumin. Implications for the pathogenesis of adrenoleukodystrophy. J Clin Invest 1994;96:1455-63.
28. Powers JM, Liu Y, Moser AB, Moser HW. The inflammatory myelinopathy of adreno-leukodystrophy: cells, effector molecules, and pathogenetic implications. J Neuropathol Exp Neurol 1992;51:630-43.